ProCAncer-I in «Big data and artificial intelligence in cancer imaging»

Published on: July 28, 2021
Categories: News

The workshop «Big data and artificial intelligence in cancer imaging», organized during IEEE BHI – BSN 2021 was held on the 27th of July 2021.

Prof Tsiknakis, as Coordinator of ProCAncer- I (www.procancer-i.eu) presented the vision, principles and challenges of the project during the first joint dissemination action of the four H2020 projects. These projects are funded under the same Action Line: AI for Health Imaging (Call: H2020-SC1-FA-DTS-2019-1): CHAIMELEON (chaimeleon.eu), EuCanImage (eucanimage.eu) and INCISIVE (incisive-project.eu).

The workshop was organized by the Coordinators of all four projects: Prof. Karim Lekadir, Universitat de Barcelona; Prof. Luis Martí-Bonmatí, La Fe University; Prof. Manolis Tsiknakis, FORTH; Mrs. Gianna Tsakou, Athens R&D Lab of Maggioli S.P.A.

During the workshop, issues were addressed mainly regarding the collaboration opportunities and challenges identified so far by all projects and the clinical considerations that arise  during the AI development and deployment in cancer imaging.

Some of the topics discussed were the anonymization of Medical Imaging Data, the data management, the AI Model of the Healthcare System of Catalonia, the AI validation (different approaches and pro’s and con’s) and the use and integration of these new technologies from the industrial point of view. Also of particular interest was the presentation on accumulated experiences from The Cancer Imaging Archive held by Prof. Fred Prior.

 

Highlights

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

ProCAncer-I in the IEEE-MeMeA Conference in Taormina

We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina! The 17th edition of IEEE International Symposium on Medical Measurements and Applications will take place in Giardini Naxos, Taormina in the metropolitan area of Messina,...

1st ProCAncer-I Project Dissemination Event in Vienna

1st ProCAncer-I Project Dissemination Event in Vienna

We are really happy to announce that we will be present at the ECR Congress in Vienna on 13 - 17 of July 2022. During the congress, a special Session will take place  on the 15th of July, presenting and discussing on the ProCAncer-I project with the title: Building...

Use Cases mapped along the prostate cancer management continuum

Use Cases mapped along the prostate cancer management continuum

Nowadays, prostate cancer is highly curable if detected in its early stages. Indeed, when organ-confined at diagnosis, the five-year survival rate of prostate cancer is close to 100%. Unfortunately, current prostate cancer diagnostic pipeline has several limitations. Prostate specific antigen (PSA) has a low sensitivity and specificity.

Stay in touch!